Works by Bergstrand, Madeleine

Results: 8

Occurrence and time course of NPS benzodiazepines in Sweden - results from intoxication cases in the STRIDA project.

Published in:

Clinical Toxicology (15563650), 2019, v. 57, n. 3, p. 203, doi. 10.1080/15563650.2018.1506130

By:

Bäckberg, Matilda;
Pettersson Bergstrand, Madeleine;
Beck, Olof;
Helander, Anders

Publication type:

Article

In vitro glucuronidation of designer benzodiazepines by human UDP‐glucuronyltransferases.

Published in:

Drug Testing & Analysis, 2019, v. 11, n. 1, p. 45, doi. 10.1002/dta.2463

By:

Pettersson Bergstrand, Madeleine;
Richter, Lilian H. J.;
Maurer, Hans H.;
Wagmann, Lea;
Meyer, Markus R.

Publication type:

Article

Human urinary metabolic patterns of the designer benzodiazepines flubromazolam and pyrazolam studied by liquid chromatography–high resolution mass spectrometry.

Published in:

Drug Testing & Analysis, 2018, v. 10, n. 3, p. 496, doi. 10.1002/dta.2243

By:

Pettersson Bergstrand, Madeleine;
Meyer, Markus R.;
Beck, Olof;
Helander, Anders

Publication type:

Article

Detectability of designer benzodiazepines in CEDIA, EMIT II Plus, HEIA, and KIMS II immunochemical screening assays.

Published in:

Drug Testing & Analysis, 2017, v. 9, n. 4, p. 640, doi. 10.1002/dta.2003

By:

Pettersson Bergstrand, Madeleine;
Helander, Anders;
Hansson, Therese;
Beck, Olof

Publication type:

Article

Sub‐ and supratherapeutic efavirenz plasma concentrations with risk for HIV therapy failure are mainly genetically explained in Ugandan children: The prospective GENEFA cohort study.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 2, p. 464, doi. 10.1111/bcp.16272

By:

Soeria‐Atmadja, Sandra;
Amuge, Pauline;
Nanzigu, Sarah;
Bbuye, Dickson;
Eriksen, Jaran;
Rubin, Johanna;
Kekitiinwa, Adeodata;
Obua, Celestino;
Dahl, Marja‐Liisa;
Pettersson Bergstrand, Madeleine;
Pohanka, Anton;
Gustafsson, Lars L.;
Navér, Lars

Publication type:

Article

Plasma concentrations of methylphenidate enantiomers in adults with ADHD and substance use disorder, with focus on high doses and relationship to carboxylesterase activity.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2022, v. 130, n. 4, p. 492, doi. 10.1111/bcpt.13707

By:

Arvidsson, Michel;
Franck, Johan;
Ackehed, Gerd;
Pettersson Bergstrand, Madeleine;
Ekström, Lena;
Rosenborg, Staffan;
Dahl, Marja‐Liisa

Publication type:

Article

In vitro metabolic fate of nine LSD-based new psychoactive substances and their analytical detectability in different urinary screening procedures.

Published in:

Analytical & Bioanalytical Chemistry, 2019, v. 411, n. 19, p. 4751, doi. 10.1007/s00216-018-1558-9

By:

Wagmann, Lea;
Richter, Lilian H. J.;
Kehl, Tobias;
Wack, Franziska;
Bergstrand, Madeleine Pettersson;
Brandt, Simon D.;
Stratford, Alexander;
Maurer, Hans H.;
Meyer, Markus R.

Publication type:

Article

Identification of main human urinary metabolites of the designer nitrobenzodiazepines clonazolam, meclonazepam, and nifoxipam by nano-liquid chromatography-high-resolution mass spectrometry for drug testing purposes.

Published in:

Analytical & Bioanalytical Chemistry, 2016, v. 408, n. 13, p. 3571, doi. 10.1007/s00216-016-9439-6

By:

Meyer, Markus;
Bergstrand, Madeleine;
Helander, Anders;
Beck, Olof

Publication type:

Article